[Author Disclosure: This content reflects the views of the author and is provided for informational purposes only. It does not constitute investment advice and is not a recommendation or endorsement by BioTech Funding Portal. Any investment decision should be based solely on the issuer’s official offering materials.]
Biotech Social debuted the BioTech Funding Portal at the BLPN Field of Dreams Summit in San Diego at the BIO2026 meeting. Glafabra Therapeutics is proud to be one of the first companies on the platform.
Starting with a Testing the Waters campaign under Regulation Crowdfunding, retail and accredited investors alike can get an early look at companies they can follow before a formal raise opens.
Soon, the platform will feature dozens of biotech companies across therapeutic areas, all in one place.
For early-stage companies like Glafabra, this matters. The traditional funding stack leaves a gap between friends-and-family and institutional Series A. Platforms like this one create a channel for mission-aligned investors to find companies before they take off with VC funding.
If you are interested in following Glafabra’s journey in gene therapy for lysosomal storage disorders, you can find us at biotech.fund/glafabra.
Exciting things are being built. Glafabra is one of them!
Register for FREE to comment or continue reading this article. Already registered? Login here.
0